Alnylam Pharmaceuticals

ALNY

NASDAQHealth Care

Income Statement

Total Revenue$2.25B

Gross Profit$1.92B

Operating Income$-176.89M

EBITDA$-178.85M

EBIT$-235.52M

Pre-tax Income$586.4M

Net Income$-278.16M

Cash Equivalent$929.18M

Total Debt$2.81B

Book Value$-30.72M

Book Value Per Share-0.24

Return on Equity (ROE)-414.62%

Return on Assets (ROA)-6.56%

Return on Invested Capital (ROI)-25.48%

Net Profit Margin-12.37%

Current Ratio2.78

Quick Ratio2.61

Long-Term Debt / Equity15.27